Related Experiment Video
Updated: Jan 20, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Activity of ceftaroline against pathogens associated with community-acquired pneumonia collected as part of the AWARE
1Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.
Abstract:
We report Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) program data for ceftaroline and comparators against isolates collected from identified lower respiratory tract sources in 2015 and 2016. MICs and susceptibility were determined using CLSI broth microdilution methodology and EUCAST breakpoints. Ceftaroline susceptibility among penicillin-resistant Streptococcus pneumoniae (MIC≥4 mg/L [nonmeningitis breakpoint]) ranged from 77.4% (Asia, 72/93) to 100% (Oceania, 16/16; Latin America, 15/15). Among MRSA, ceftaroline susceptibility ranged from 72.3% (Asia, 553/765) to 100% (Oceania, 39/39). Among β-lactamase-positive Haemophilus influenzae, ceftaroline susceptibility ranged from 69.2% (Asia, 36/52) to 100% (Oceania, 19/19). Susceptibility to ceftaroline against non-ESBL-producing Klebsiella pneumoniae was between 91.4% (Europe, 659/721) and 100% (Oceania, 55/55) and for Escherichia coli between 85.7% (Africa/Middle East, 42/49) and 92.1% (Oceania, 35/38). Ceftaroline is not active against ESBL producers. In this study, susceptibility to ceftaroline was high among the S. pneumoniae, Staphylococcus aureus, β-lactamase-negative H. influenzae, and ESBL-negative K. pneumoniae and E. coli collected.
Insights
Ceftaroline shows high susceptibility against common respiratory pathogens like Streptococcus pneumoniae and MRSA, but is not effective against ESBL-producing bacteria. This global data highlights ceftaroline
Area of Science:
- Clinical Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Antimicrobial resistance is a growing global health threat.
- Ceftaroline is a cephalosporin antibiotic with activity against Gram-positive and some Gram-negative bacteria.
- Understanding regional susceptibility patterns is crucial for effective treatment.
Purpose of the Study:
- To evaluate the global activity of ceftaroline against key respiratory pathogens.
- To assess ceftaroline susceptibility in Streptococcus pneumoniae, Staphylococcus aureus (MRSA), Haemophilus influenzae, Klebsiella pneumoniae, and Escherichia coli.
- To analyze data from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) program.
Main Methods:
- Analysis of isolates collected from lower respiratory tract infections in 2015-2016.
- Minimum Inhibitory Concentrations (MICs) determined by CLSI broth microdilution.
- Susceptibility interpreted using EUCAST breakpoints.
Main Results:
- High ceftaroline susceptibility observed for penicillin-resistant S. pneumoniae (77.4%-100%) and MRSA (72.3%-100%) across regions.
- Ceftaroline demonstrated good activity against beta-lactamase-positive H. influenzae (69.2%-100%) and non-ESBL-producing K. pneumoniae (91.4%-100%) and E. coli (85.7%-92.1%).
- Ceftaroline was not active against ESBL-producing Enterobacteriaceae.
Conclusions:
- Ceftaroline exhibits significant in vitro activity against key Gram-positive and Gram-negative respiratory pathogens globally.
- Susceptibility to ceftaroline remains high for common resistant pathogens like penicillin-resistant S. pneumoniae and MRSA.
- Ceftaroline is not a reliable option for infections caused by ESBL-producing bacteria.
Related Concept Videos
Self-Awareness and Its Effects
Altered States of Awareness
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
Subconsciousness and No Awareness
An illustrative example of subconscious processing is its role in problem-solving. Often, individuals...
What are Populations and Communities?
High-Level and Low-Level Awareness
Principles of Disease Surveillance

